USPTO trademark

AstraZeneca AB design mark 99454212

AllowedUSPTOFigurative markClass 5

"Design mark 99454212" is a figurative mark owned by AstraZeneca AB, filed at the USPTO on October 29, 2025. It has been allowed and covers class 5 (Pharmaceuticals).

View AstraZeneca AB portfolioGet this data via the API
Official USPTO record
AstraZeneca AB design mark 99454212 trademark as filed
As filed with the USPTO
Status
Allowed
Since June 9, 2026
Filed
October 29, 2025
Registered
Not yet
Expires
Not recorded
Application no.
99454212
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Figurative mark
1 class
Ownership

Who owns AstraZeneca AB design mark 99454212

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

AstraZeneca AB

Sodertalje, Sweden

6,107 trademarks in the portfolioView company

Representative

Leonid Rakitin

AstraZeneca Pharmaceuticals LP

Goods and services

What the mark covers

The products and services AstraZeneca AB design mark 99454212 is filed for, grouped by Nice class.

  • Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, dermatological, neurological, gastrointestinal, and immune systems; Pharmaceutical preparations for the treatment of infection, inflammation, hematological, and autoimmune related diseases and disorders; Antibodies for medical purposes; Vaccines

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Teas delete 1(b) basis received
  2. Teas change of correspondence received
  3. Attorney/dom.rep.revoked and/or appointed
  4. Teas revoke/app/change addr of atty/dom rep received
  5. Noa e-mailed - sou required from applicant
  6. Official gazette publication confirmation e-mailed
  7. Published for opposition
  8. Notification of notice of publication e-mailed
  9. Approved for pub - principal register
  10. Assigned to examiner

4 earlier steps on the official record.

FAQ

About AstraZeneca AB design mark 99454212

Who owns the trademark "Design mark 99454212"?

The USPTO trademark "Design mark 99454212" (application 99454212) is owned by AstraZeneca AB.

What is the status of "Design mark 99454212"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull AstraZeneca AB design mark 99454212 and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2b4a-46c6-7188-92cb-65aa59bc9c81
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2b4a-46c6-7188-92cb-65aa59bc9c81",
  "object": "trademark",
  "mark_text": "[Design Mark]",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "99454212",
  "filing_date": "2025-10-29",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "AstraZeneca AB",
      "entity_id": "ent_019eb700-571d-718e-bf3d-80fe37712629"
    }
  ]
}